Uncertainties in Radiation Dosimetry and their Impact on Risk Analysis
May 8, 2009
Washington D.C.

The purpose of the workshop, organized by the National Cancer Institute and sponsored by the National Institute for Allergy and Infectious Diseases (NIAID), was to explore how uncertainties in individual dose estimates affect the statistical power and shape of the dose response in epidemiologic investigations. It was a follow-up of a workshop that was held by the National Cancer Institute on the same topic in September 1997. This page provides a link to Adobe Acrobat pdf files of MS Power Point presentations made at the May 8th workshop that was held at the Georgetown University Conference Center in Washington D.C. The presentations are listed in the order in which they were given. In the days after the workshop there was continued discussion that occurred via e-mail. A link to these discussions are also included in the table below.

Presenter
Affiliation
Title of Presentation
Link to file
Dr. F. Owen Hoffman
SENES Oak Ridge, Inc.
Quantifying Uncertainty in Dose - From the perspective of a person who evaluates uncertainty in environmental pathway models
Dr. Ethel S. Gilbert
National Cancer Institute
Point of View of the Statistician
Dr. Roy Shore
Radiation Effects Research Foundation
Thoughts on Estimating Radiation Doses from an Epidemiologic Perspective
Dr. Harry M. Cullings
Radiation Effects Research Foundation
Size and Structure of the Estimated Uncertainty in Radiation Doses received by the Atomic Bomb Survivors in Hiroshima and Nagasaki
Dr. Donald A. Pierce
RERF - Retired
Allowance for dose-estimation errors in RERF data
Dr. Dale Preston
HIRO Soft, Inc./ NCI
Dose Uncertainty and A-bomb Survivor Risk Estimates: Possible Improvements
Dr. Steven.L. Simon
National Cancer Institute
The NCI Schema for Incorporation Uncertainty into Estimates of Radiation Dose in a Study of Thyroid Disease in Kazakhstan
Dr. Deukwoo Kwon
National Cancer Institute
Kazakhstan Study: Approaches/Methods in incorporate Dose Uncertainty into Risk Assessment
Dr. Charles Land
National Cancer Institute
Kazakhstan - Possible Improvements
Dr. Vladimir Drozdovitch
National Cancer Institute
Quantification and organization of dose uncertainties in IARC thyroid cancer study
Dr. Elisabeth Cardis
CREAL Barcelona, Spain
Risk of Thyroid Cancer following 131I Exposure in Childhood-Belarus/Russia/EU/IARC Case-Control Study
Dr. Andre Bouville
National Cancer Institute
Epidemiology Branch Case Study 3b: NCI's Cohort Study
Dr. Alina Brenner
National Cancer Institute
Cohort Study of Thyroid Cancer and other Thyroid Diseases following the Chernobyl accident - analysis of dose-response
Dr. Donna Spiegelman
Dept. of Epidemiology and Biostatistics, Harvard
The effect of exposure measurement error (aka dose uncertainties) on hazard assessment and dose-response estimation in linear and non-linear models
Mr. Eduard Hofer
Dorfen, Germany
How is the Statistical Power of Hypothesis Tests affected by Dose Uncertainty?
Dr. Daniel J. Strom
Pacific Northwest National Laboratory
Observations on Uncertainties in Dosimetry
    Follow-up Discussions